Category: Person Career
|
|
| |
|
California Life Science Firms to Learn "Insider" Strategies for Government Funding at 11th SoCalBio Investor & Partnership Conference
|
 |
BIOCOM and BayBio are creating a day and a half conference that will combine the business, research and investment aspects for the industrial biotech community in this unique statewide conference. Through panel discussions, partnering opportunities and ample networking opportunities to extend your relationships. This conference will educate participants on the opportunities and challenges facing industrial biotech companies and ultimately demonstrate why California is a center of innovation in the industrial biotech space.
Newly funded companies create medical innovations, help businesses improve productivity
PHILADELPHIA, PA (www.sep.benfranklin.org) – Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved investments totaling $1,800,000 for nine early-stage Pennsylvania companies with promising technology innovations. Included in this is a $500,000 investment in Molecular Detection Inc. (MDI). MDI developed a quick method to detect drug resistant Staph infections. Investment details follow.
Council will advise the president on ways to foster entrepreneurship and transform laboratory ideas into new businesses and jobs
ANN ARBOR, Mich. – U.S. Commerce Secretary Gary Locke today announced the members of the National Advisory Council on Innovation and Entrepreneurship, a group that will support President Obama's innovation strategy by helping to develop policies that foster entrepreneurship and identifying new ways to take great ideas from the lab to the marketplace to drive economic growth and create jobs. Locke made the announcement at a U.S. Department of Commerce University Innovation Forum at the University of Michigan, where participants discussed the role of universities in innovation, economic development, job creation and commercialization of federally funded research.
The National Advisory Council on Innovation and Entrepreneurship will help build on this aggressive agenda. Members of the council include serial entrepreneurs, university presidents, investors and non-profit leaders. Steve Case, Mary Sue Coleman, and Desh Deshpande will serve as Co-Chairs. See the full list of council members below.
Tucson 12 brings you The UPSIDE, a web-based video series with one main mission... to tell the stories of people who are working to make Tucson a great city.
Great Video of the UA Tech Park
Thanks, Jessa
http://www.uatechpark.org/
In business, the decision to support an initiative is frequently made following a live presentation supported by slides. Too often these presentations miss the mark. Cruxio specializes in equipping biomedical companies to develop and deliver clear, powerful strategic stories - usually as live presentations. In the past four years, Cruxio's unique story-development methodology has fueled more than 50 mission-critical presentations, helping to secure more than $500 million in funds or revenue. Join Rob Wishnowsky, founder of Cruxio - the crux of the story - for an interactive overview of five essentials you need to consider to develop your clear, compelling strategic story.
In 2005 Rob Wishnowsky founded Cruxio (the crux of the story), a West Coast company that helps companies develop and deliver clear strategic stories. Cruxio's proprietary processes have been used in more than fifty presentations, securing more than $500 million in funding or revenue. Rob has extensive experience in global strategy, sales and marketing in the fields of life science, diagnostics and biotechnology. 20 years he has led business units, sales forces, strategy formulation, market segmentation, portfolio development and marketing execution, primarily in large corporations (Boehringer Mannheim/Roche Diagnostics, Johnson & Johnson's Lifescan) as well as in early-stage companies. He served on the board of the Biomedical Marketing Association from 2003 to 2007.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=206505
What Does Healthcare Reform Mean to
San Diego Businesses?
The recently passed Patient Protection and Affordable Care Act (or healthcare reform law) is attempting to insure more Americans, lower costs and impose new taxes on medical devices. How does the enactment of this far reaching legislation change the way San Diego wireless health and life sciences companies conduct business? San Diego has played an important foundational role in the formation of the wireless healthcare market. How do Don Casey, the CEO of the West Wireless Health Institute,Mike Murphy, the CEO of Sharp Hospitals and Dave Schlotterbeck, the CEO of CareFusion, view this important piece of legislation? What are the opportunities, threats and possibilities for San Diego businesses and how will this industry respond to the new law.
The panel is preceded by a Wireless Health Expo featuring the latest innovations in wireless health products and services. Attendees have an opportunity to experience the latest technologies as well as network with industry representatives from the mHealth sector.
Firms Offer EBC Companies Access to Leading Design Software to Speed Time to Market for Clean Energy and Environmental Technologies
SAN JOSE and SAN RAFAEL, Calif., July 13, 2010 — Autodesk, Inc. (NASDAQ: ADSK) and the Environmental Business Cluster (EBC) have forged an industry partnership to offer benefits of the Autodesk Clean Tech Partner Program to the EBC community so companies can innovate and commercialize their ideas more quickly.
EBC is an award-winning clean tech incubator in Silicon Valley that provides commercialization support and facilities for emerging clean energy and environmental technology companies. The Autodesk Clean Tech Partner Program provides Digital Prototyping software to clean technology companies to enable them to digitally design, visualize and simulate the real-world performance of products before they are built. Creation of digital prototypes can serve as a catalyst to help participants secure financing and effectively market their ideas.
Participation comes from academic institutions and companies across the state
Waltham, Massachusetts - The Massachusetts Life Sciences Center’s 2010 Internship Challenge has received an overwhelming response since its February launch, with nearly 900 applicants seeking internships this summer. Over 130 companies from all sectors of the life sciences community have combed through hundreds of resumes, held numerous interviews, and selected interns to hire. Through the Challenge, 164 interns have been matched with 93 life sciences companies, a more than 50% increase from the 104 interns selected in 2009.
The Massachusetts Life Sciences Center’s Internship Challenge is a workforce development program focused on enhancing the talent pipeline for life sciences companies in Massachusetts while providing interns with practical, “hands on” experience that prepares them to step into the workforce ready to meet the job requirements of life sciences employers. The program is providing paid summer internships to undergraduates, graduate students, and recent college graduates from 46 different colleges and universities.
UC Berkeley, Deloitte and Prescience, Intl. are proud to offer 10 scholarships to the BioExec Institute 2010. Part of the success of this internationally-renowned program has been the diversity and depth of its participants, which has created a strong and powerful alumni network in this industry. We would therefore like to offer scholarships to the leadership of small companies with annual revenues under $10M and to academics, as well as employees of governmental and/or non-profit organizations. These scholarships finance nearly 50% of an attendee's program registration fee.
This is a rolling application process. Please click here to download the application form and submit to Chelsea Hewitt at chelsea@prescienceintl.com. You will be notified if your application is accepted within one week of your submission. Some of this year's faculty and speakers include:
- Mervyn J. Turner, Ph.D., Chief Strategy Officer, Merck & Co. Inc. & Sr. Vice President, Emerging Markets, Merck Research Laboratories
- Mark Edwards, President, Deloitte Recap, LLC
- Barbara Ryan, Managing Director, Deutsche Bank
- Dave Summa, Board of Directors, Sequoia Pharmaceuticals, Acumen Pharmaceuticals, and Agrivida, Inc.
- Christopher S. Boerner, Group Product Manager, Xolair Marketing, Genentech
- David Kessler, MD, JD, Best Selling Author and Former Commissioner of the US Food and Drug Administration (FDA)
- Martin Babler, President and CEO, Talima Therapeutics Inc.
- Casper DeClerq, Venture Partner, US Venture Partners
- Scott Evangelista, Principal, National Commercial Practice Leader, Deloitte Consulting LLP
- Dennis Schmatz, PhD, President, Medicines for Malaria Venture NA; Chair - Expert Scientific Advisory Board (ESAC) Medicines for Malaria Venture, Board Member,Medicines for Malaria Venture
- Keith Donnermeyer, Partner and National Life Sciences Sector Leader, Deloitte & Touche LLP
- Abhay Joshi, PhD, President & CEO, Alvine Pharmaceuticals
- Brian McRee, Director, Commercial Supply Planning, Genentech
- Kuo Bianchini Tong, Founder & President, Quorum Consulting
